Synopsis
0
EU WC
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 1%
USFDA APPLICATION NUMBER - 12250
DOSAGE - INJECTABLE;INJECTION - 1.5%
USFDA APPLICATION NUMBER - 12250
DOSAGE - INJECTABLE;INJECTION - 2%
USFDA APPLICATION NUMBER - 12250
Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Controlled & Modified Release
Fillers, Diluents & Binders
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
76
PharmaCompass offers a list of Mepivacaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mepivacaine Hydrochloride manufacturer or Mepivacaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mepivacaine Hydrochloride manufacturer or Mepivacaine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Mepivacaine Hydrochloride API Price utilized in the formulation of products. Mepivacaine Hydrochloride API Price is not always fixed or binding as the Mepivacaine Hydrochloride Price is obtained through a variety of data sources. The Mepivacaine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mepivastesin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mepivastesin, including repackagers and relabelers. The FDA regulates Mepivastesin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mepivastesin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mepivastesin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mepivastesin supplier is an individual or a company that provides Mepivastesin active pharmaceutical ingredient (API) or Mepivastesin finished formulations upon request. The Mepivastesin suppliers may include Mepivastesin API manufacturers, exporters, distributors and traders.
click here to find a list of Mepivastesin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mepivastesin DMF (Drug Master File) is a document detailing the whole manufacturing process of Mepivastesin active pharmaceutical ingredient (API) in detail. Different forms of Mepivastesin DMFs exist exist since differing nations have different regulations, such as Mepivastesin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mepivastesin DMF submitted to regulatory agencies in the US is known as a USDMF. Mepivastesin USDMF includes data on Mepivastesin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mepivastesin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mepivastesin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mepivastesin Drug Master File in Japan (Mepivastesin JDMF) empowers Mepivastesin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mepivastesin JDMF during the approval evaluation for pharmaceutical products. At the time of Mepivastesin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mepivastesin suppliers with JDMF on PharmaCompass.
A Mepivastesin CEP of the European Pharmacopoeia monograph is often referred to as a Mepivastesin Certificate of Suitability (COS). The purpose of a Mepivastesin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mepivastesin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mepivastesin to their clients by showing that a Mepivastesin CEP has been issued for it. The manufacturer submits a Mepivastesin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mepivastesin CEP holder for the record. Additionally, the data presented in the Mepivastesin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mepivastesin DMF.
A Mepivastesin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mepivastesin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mepivastesin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mepivastesin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mepivastesin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mepivastesin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mepivastesin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mepivastesin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mepivastesin suppliers with NDC on PharmaCompass.
Mepivastesin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mepivastesin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mepivastesin GMP manufacturer or Mepivastesin GMP API supplier for your needs.
A Mepivastesin CoA (Certificate of Analysis) is a formal document that attests to Mepivastesin's compliance with Mepivastesin specifications and serves as a tool for batch-level quality control.
Mepivastesin CoA mostly includes findings from lab analyses of a specific batch. For each Mepivastesin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mepivastesin may be tested according to a variety of international standards, such as European Pharmacopoeia (Mepivastesin EP), Mepivastesin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mepivastesin USP).
